Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Highlights of 2025: advancements in natural killer cell biology.

Immunology and cell biology·2026

Same author

The GFI1-FOXO1 axis regulates NK cell maturation and function.

Nature communications·2026

Same author

CAR-NK cell-based therapies: translational and regulatory breakthroughs.

Immunology and cell biology·2026

Same author

Hospital-at-Home for South Asian Communities in British Columbia, Canada: Qualitative Interview Study.

JMIR human factors·2026

Same author

Cytokine routing as an overlooked determinant of immune mobilization.

Immunology and cell biology·2025

Same author

Designing for Patient-Centered Care and Equity in Virtual Hospital-at-Home Models: Quality Improvement Initiative Using Experience-Based Co-Design.

JMIR human factors·2025

Search research articles

Related Experiment Video

Updated: Apr 11, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Gain-of-function enhancers optimize CAR-NK cell-based anti-cancer immunotherapy.

Emma Wong¹, Fernando Souza-Fonseca-Guimaraes¹

¹Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Woolloongabba, QLD, Australia.

Immunology and Cell Biology

|April 10, 2026

Summary

This summary is machine-generated.

This study identifies natural killer (NK) cell fitness genes using a two-stage CRISPR screening approach. These findings enhance understanding of NK cell function for potential cancer immunotherapy applications.

More Related Videos

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Experiment Videos

Last Updated: Apr 11, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Area of Science:

Immunology
Molecular Biology
Cancer Research

Background:

Natural killer (NK) cells are crucial for innate immunity and cancer surveillance.
Enhancing NK cell fitness is a key strategy for improving adoptive cell therapies.
CRISPR activation (CRISPRa) offers a powerful tool for functional genomics screens.

Purpose of the Study:

To identify genes that regulate the fitness and function of chimeric antigen receptor (CAR)-engineered NK cells.
To develop and validate a two-stage screening approach for NK cell fitness genes.

Main Methods:

A whole-genome CRISPRa screen was performed in HER2-CAR-NK92 cells in a mouse xenograft model.
A barcoded open reading frame (ORF) mini-screen was conducted in primary peripheral blood NK (PBNK) cells engineered with HER2-CAR.
Both screens utilized next-generation sequencing (NGS) to identify genes modulating NK cell fitness in the tumor microenvironment.

Main Results:

The study successfully implemented a two-stage CRISPRa screening strategy to identify NK cell fitness genes.
The methodology allowed for the assessment of gene function in both engineered cell lines and primary NK cells within a tumor-bearing mouse model.

Conclusions:

The developed screening approach is effective for discovering genes that impact NK cell fitness and anti-tumor activity.
This research provides a foundation for future studies aimed at optimizing NK cell-based immunotherapies.